Turning Point Therapeutics, Inc.
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. The company focuses on research and development in areas such as oncology, hematology, immunology, and cardiovascular diseases, aiming to transform patients' lives through science.
Industries
Nr. of Employees
large (251-1000)
Turning Point Therapeutics, Inc.
San Diego, California, United States, North America
Products
Approved biopharmaceutical medicines across multiple therapeutic areas
Approved therapeutic agents indicated for treatment of serious diseases in oncology, hematology, immunology and cardiovascular medicine, accompanied by professional product information and labeling.
Approved biopharmaceutical medicines across multiple therapeutic areas
Approved therapeutic agents indicated for treatment of serious diseases in oncology, hematology, immunology and cardiovascular medicine, accompanied by professional product information and labeling.
Services
Clinical trial information and participant‑matching platform
Public web platform listing clinical studies and providing tools to match patients and investigators to appropriate trials.
Pharmacovigilance and adverse‑event reporting service
Global reporting channels and regional contact points for safety reporting and product quality issues.
Medical information services for healthcare providers
Contact‑center and online portal services providing clinical and product information to healthcare professionals.
Medical education grants and investigator training
Grant funding, scholarships and sponsored rotations to support clinician education, conference attendance and investigator capacity building.
Patient education and support programs
Digital resources and outreach campaigns offering disease education, survivorship resources and therapy‑specific guidance for patients and caregivers.
Scientific communications and public news platform
Creation and curation of scientific articles, news, perspectives and institutional reports for external audiences.
Clinical trial information and participant‑matching platform
Public web platform listing clinical studies and providing tools to match patients and investigators to appropriate trials.
Pharmacovigilance and adverse‑event reporting service
Global reporting channels and regional contact points for safety reporting and product quality issues.
Medical information services for healthcare providers
Contact‑center and online portal services providing clinical and product information to healthcare professionals.
Medical education grants and investigator training
Grant funding, scholarships and sponsored rotations to support clinician education, conference attendance and investigator capacity building.
Patient education and support programs
Digital resources and outreach campaigns offering disease education, survivorship resources and therapy‑specific guidance for patients and caregivers.
Scientific communications and public news platform
Creation and curation of scientific articles, news, perspectives and institutional reports for external audiences.
Expertise Areas
- Clinical trial management and recruitment
- Pharmacovigilance and safety surveillance
- Regulatory affairs and submissions
- Cell therapy development and clinical support
Key Technologies
- Cell therapy (CAR‑T and other cellular modalities)
- Immuno‑oncology therapeutics
- Whole‑genome sequencing
- Clinical trial matching and registry platforms